Aurobindo Pharma reports marginal rise in Q2 consolidated net profit
The consolidated total income of the company increased by 5.98% at Rs 8,406.29 crore for Q2FY26
Aurobindo Pharma has reported result for second quarter ended September 30, 2025 (Q2FY26).
The company has reported 8.16% rise in its net profit at Rs 581.37 crore for the quarter ended September 30, 2025 as compared to Rs 537.53 crore for the same quarter in the previous year. The total income of the company increased by 0.07% at Rs 2,949.24 crore for Q2FY26 as compared to Rs 2,947.25 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 3.80% rise in its net profit at Rs 848.45 crore for Q2FY26 as compared to Rs 817.38 crore for the same quarter in the previous year. The total income of the company increased by 5.98% at Rs 8,406.29 crore for Q2FY26 as compared to Rs 7,932.07 crore for the corresponding quarter previous year.
